Profit Matters!  Small Stocks. Huge Gains.
  • Home
  • Market News
  • HOT Picks
  • FREE OFFER
  • Services
  • About
  • SUCCESS Stories
  • Clients
  • Contact
Epic, EPOR, Market Summary, Profile  E-mail
Written by Administrator   
Sunday, 01 July 2012 20:56

 

company spotlight

 

Epic (EPOR) Market Summary

 

Epic is a publicly traded company, since its founding in 1997, the company has focused on Research and Development of Healthcare products. Epic's goal is to make a meaningful difference in the lives of millions of Americans who are suffering from chronic pains.

(Note:-OxBridge has just released a comprehensive Market Intelligence Report on EPOR) see the full Report

 

 

AcuFABTM

The company has successfully developed a specially engineered fabric called AcuFABTM, which improves blood circulation to the pressure points and sore joints, providing great comfort and relief from chronic pains.

 

EPIC sells 'the fabric' to the Original Equipment Manufacturers (OEMs), these manufacturers make, various products using the AcuFabTM, and sell directly to consumers and healthcare institutions under their own Brand names.

 

AcuPADTM

EPIC also makes its own Branded products, with AcuFABTM, under the name AcuPADTM. AcuPADs are sold directly to healthcare institutions and consumers through the company's website www.epiccor.com, Amazon.com and other distributors.

 

Business Model

Epic’s business model is similar to Intel’s famous “intel inside” model, where Intel supplies CPUs to companies like Dell and HP and these OEMs incorporate intel’s technology into their PCs and Laptops.

 

The Opportunity

Epic Corporation has a proprietary and patent protected manufacturing process for a fabric solution which offers great advantages to the surface tissue. In a world where we have major problems with sedentary lifestyles, poor eating habits, and healthcare issues, these solutions may be the answer for patients everywhere. What is most intriguing is that these products have some technological barriers to entry yet do not have to go through the rigorous FDA approval process.

 

Epic's Solutions for Healthcare Crisis

American healthcare system is under severe strain and the healthcare costs are rising rapidly, Obesity and Diabetes increasing dramatically due to diet and sedentary life style. EPIC’s preventative solutions for chronic pains could provide relief from pain and financial burden.

read the full Report

 

Last Updated on Friday, 06 July 2012 16:17
 
Entree Gold, EGI, Summary, Profile  E-mail
Written by Administrator   
Tuesday, 05 June 2012 23:48

 

 

Entree Gold | EGI | Summary | Profile

 

Entrée Gold (EGI) is a Canadian mineral exploration company focused on the worldwide discovery and development of copper and gold prospects. The Company has significant interests in three key copper porphyry deposits: the Hugo North Extension and the Heruga deposits in Mongolia, and the Ann Mason deposit, located near Yerington, Nevada.

The Lookout Hill property in Mongolia completely surrounds the Oyu Tolgoi mining, a subsidiary of Ivanhoe Mines and the Government of Mongolia.

 

The Company is also exploring for porphyry-related copper systems in Nevada and New Mexico. The primary North American asset is the Ann Mason Project, located near Yerington, Nevada.

The Yerington copper camp has seen significant historic copper production along with a resurgence of exploration activity and now hosts over 20 billion pounds of copper in several deposits owned by a diverse group of companies.

 

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® we received or expecting compensation from the featured company or a third party. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

 
Stock to Watch, Emgold Mining, EMR.V, EGMCF.PK  E-mail
Written by Administrator   
Wednesday, 02 May 2012 01:53

 

Stock to Watch!

Emgold Mining Corp. EMR (TSX.V) EGMCF (OTCQB)

Emgold Mining Corporation is a gold exploration and development company with five exploration and development projects in North America. The Company is focused on acquiring and developing quality properties, and advancing them through exploration, permitting, construction, and ultimately create a new gold producing company.

Focus

The Company is focused on reopening the historic Idaho-Maryland Gold Mine located in Grass Valley, California. The Company plans to develop a 2,400 ton per day mining operation with potential to produce over 200,000 ounces of gold per year.

Additional Properties

Emgold Mining also has a portfolio of four early to middle stage mineral exploration projects including the Buckskin-Rawhide Property, and the Koegel Rawhide Property in Nevada, the Stewart Property, and the Rozan Property in British Columbia.

INVESTMENT HIGHLIGHTS

  • Opportunity to invest in a world class gold asset whose main property has potential to develop a 3-5 million ounce gold resource.

  • Idaho-Maryland Project in California has significant gold resources and production potential

    • Measured & Indicated: 472,000 ounces of gold. Inferred: 1,002,000 ounces of gold.

    • Company planning to produce over 200,000 ounces of gold annually.

    • 13 million ounces of gold was produced within 3 mile radius, see why Emgold's has been involved with this property since 1993!

  • Four additional excellent exploration properties in Nevada and British Columbia. Learn more about these great properties.

  • The Company’s gold assets and solid resource base seems to be currently undervalued with the stock trading at $0.10 per share, implied value per ounce of only $4 per ounce of gold. See the Valuation

  • The Company successfully raised $2.2 million and planning to raise additional funds to advance Idaho-Maryland project.

  • Strong management team and Board of Directors with considerable exploration and development mining experience. Learn more about Management Team!

  • Find out the 'Target Price', read the compelling analysis.

  • Full Report is now available for FREE! download now.

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company or a third party. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

 
Ecosphere Technologies, ESPH.OB, Summary, Profile  E-mail
Written by Administrator   
Saturday, 14 April 2012 21:04

 

Ecosphere Technologies | ESPH.OB | Summary | Profile

 

Ecosphere Technologies, ESPH.OB, is a diversified engineering and technology company, engaged in clean technologies and services.

 

The company designs and builds mobile water filtration equipment, waste water treatment and provides water recycling services to the energy exploration companies.

 

Ozonix®

The company's patented Ozonix technology is primarily used by the gas and oil companies for treatment and recycling of water used in fracking. The technology eliminates, bacteria and reduces scaling, eliminating the need to dispose the contaminated water. This process helps Oil&Gas companies save money and improve productivity.

 

Mobile, High-Volume Fluid Reclamation:

  • Ozonix® Eliminates Liquid Chemical Biocides

  • Provides Rapid On-Site Water Reclamation

  • Oxidizes Contaminates, Killing Bacteria and Destroying Bacteria Cell Walls On-the-Fly

  • Eliminates Costly Biocides and Reduces Scale Inhibitors Needed for Corrosion Control

  • Eliminates the Costs Associated with Waste Separation, Transportation & Disposal

  • High-Volume Water Treatment Capabilities allow for Quick Turnaround Time and Increased Utilization

  • Self-Contained Ozonix® Systems offer Minimal Mobilization and Demobilization Arrangements

  • Environmentally Safe, Eliminating Hazardous Waste Byproducts and Residual Pollutants

  • Ozonix® Preserves Natural Water Resources Minimizing Customers' Carbon Footprints

 

The Shale Gas industry is expanding at a rapid pace, waste water treatment, recycling and chemicals used in the process of fracking is a major environmental concern. The company's has developed a technology that doesn't require any chemicals. The company has a great technology serving the growing need of Oil & GAS, Mining Industries and Municipalities, and an Excellent management team, Keep an eye!


Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Last Updated on Saturday, 14 April 2012 21:11
 
Marina Biotech, MRNA, Summary, Profile  E-mail
Written by Administrator   
Friday, 30 March 2012 12:10

 

Marina Biotech | MRNA | Summary | Profile

 

Marina Biotech – MRNA - is focused on the discovery and development of novel RNAi-based therapeutics in the area of oncology, bladder and liver cancer.

 

The company is exploring the potential of RNAi-based therapeutics through the development of multiple broad-based, state-of-the-art drug discovery platforms built upon industry leading expertise in RNA chemistry, microbiology and oligonucleotide delivery.

Bladder Cancer

Marina Biotech is conducting preclinical studies in bladder cancer utilizing our tauRNAi platform. Bladder cancer ranks as the 4th most common cancer in men, and the 9th leading cause of death in men in the US. Approximately 75% of all bladder cancer cases in the US are in men. In the US, it is currently estimated that on a yearly basis, more than 70,000 new patients will be diagnosed with bladder cancer and approximately 15,000 deaths will occur from bladder cancer.

Liver Cancer

Marina Biotech is utilizing the tauRNAi platform in preclinical studies of hepatocellular carcinoma, more commonly known as liver cancer. Leading causes of liver cancer include viral infection (hepatitis), toxins, and damage to the liver that result in cirrhosis. Worldwide there are more than 500,000 new cases of liver cancer each year. It is currently estimated that in the US, more than 20,000 new cases of liver cancer will be diagnosed and 19,000 deaths are expected to occur due to liver cancer.

 

The company has partnered with World's leading companies and universities, including University of Michigan and University of Helsinki. The partners include Roche and Novartis.

 

The stock is trading near 52WK LOWS, may bounce back keep an eye!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

 
Shengkai Innovations | VALV | Profile | Summary  E-mail
Written by Administrator   
Wednesday, 07 March 2012 11:41

 

Shengkai Innovations – VALV - is engaged in the design, manufacture and sale of ceramic valves, high-tech ceramic materials and the provision of technical consultation and related services. The Company's industrial valve products are used by companies in the electric power, petrochemical and chemical, metallurgy and other industries as high-performance, more durable alternatives to traditional metal valves.


The Company is one of the few ceramic valve manufacturers in the world with research and development, engineering, and production capacity for structural ceramics and is able to produce large-sized ceramic valves with calibers of 6" (150mm) or more.


Shengkai Innovations product portfolio includes a broad range of valves that are sold throughout the PRC, to Europe, North America, United Arab Emirates, and other countries in the Asia-Pacific region. The Company has over 400 customers. The Company is a member of the Petro-China supply network and the only ceramic valve supplier qualified to supply SINOPEC.

VALV is trading near 52WK Lows, could bounce back from these levels, keep an eye!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Last Updated on Monday, 19 March 2012 09:32
 
FDA's surprise Valentine Gift to WOMEN!  E-mail
Written by Administrator   
Wednesday, 15 February 2012 12:39

 

 

FDA's surprise Valentine Gift to WOMEN!

 

Who says FDA doesn't know anything about romance? We are pretty sure nothing like this ever happened before, the greatest romantic gesture in the history of FDA and the timing was priceless!

 

On Valentine eve FDA delivered a surprise gift, Ladies: its NOT long stem Roses, something Better! FDA said YES! to Gel. FDA has approved BioSante's Bio-T-Gel. BPAX estimates the market for Male Dysfunction drugs in the US alone is $1.2 Billion Dollars.

 

We alerted our members on Jan 17th when the stock was trading near the 52WK Lows, our headline read “BPAX shareholders wonder if there is a Gel for stock dysfunction!”

 

Well, there you have it, FDA answered the prayers and BPAX is UP a whopping 107% ! our members are ecstatic. Are you Gellin'?

 

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we receive compensation from companies we feature, Always Read the full Disclosure/Disclaimer. Thanks.

Last Updated on Wednesday, 15 February 2012 13:08
 
More Articles...
  • DayStar Technologies | DSTI | Profile | Summary
  • CHGS, China Geng Sheng Minerals, Profile, Summary
  • BNVI, Bionovo, Delivers a Healthy 43% Returns in 5 days!
  • Improving women's health and sex life, Bionovo, BNVI
«StartPrev12345678910NextEnd»

Page 6 of 65
Tweet
feed-image Feed Entries
 

Today's Top Pick

Get it Now!

 

 

BNVI +43%
RDDY +50%
PTEK +64%
WEST +47%
BPAX +107%
ZOOM +24%
HYSR +69%
Small Stocks. Huge Gains.

 

 

Top 10 Picks
  • ERTS + 9.12%
  • CLWR + 147,56%
  • GSOL + 82.71%
  • DRYS + 57.21%
  • RMG + 28.98%
  • FCX + 142.87%
  • BX + 133.33%
  • RIM + 66.12%
  • CREE + 180.35%
  • MMR + 194.08%
  • Details
Latest Reports


 

  • Green Innovations,GNIN, Profile

  • LiveWire Energy, LVVV, Profile

  • Stevia (STEV) Research Report new

  • STEV – Stevia Profile

  • Epic (EPOR) Market Intelligence Report new

  • Epic (EPOR) Market Summary new

  • Emgold (EMR.V) Research Report new

  • Emgold (EMR.V, EMGCF) Profile new

  • DTOR.OB, Del Toro, Profile
  • SIGNATURE DEVICES SDVI.PK
  • ZenZuu.com   TCLN.OB
  • HEARTLAND  HTOG.PK
  • ALUMIFUEL POWER  AFPW.OB
  • AFPW.OB  New Update
  • New Energy  NENE.OB
  • Tale of Two Energy Stocks
  • TBIO TRANSGENOMIC
  • GETG, GREEN EARTH TECH
  • UBRG, Universal Bioenergy Profile
  • UBRG Research Report new

 

Most Active
Tweet  



Disclosure/Disclaimer Terms and Conditions.
© Copyright 2007 OxbridgeResearch.com, All Rights Reserved. Trademarks/logos are of their respective owners.